Fisher M, et al.. AKI in hospitalized patients with and without COVID-19: A comparison study. J Am Soc Nephrol 2020; 31:2145−2157. doi: 10.1681/ASN.2020040509

• Crossref
Fisher M, . AKI in hospitalized patients with and without COVID-19: A comparison study. J Am Soc Nephrol 2020; 31:2145−2157. doi: 10.1681/ASN.202004050910.1681/ASN.2020040509)| false
• Search Google Scholar
• Export Citation

Sourial MY, et al.. Urgent peritoneal dialysis in patients with COVID-19 and acute kidney injury: A single-center experience in a time of crisis in the United States. Am J Kidney Dis 2020; 76:401−406. doi: 10.1053/j.ajkd.2020.06.001

• Crossref
Sourial MY, . Urgent peritoneal dialysis in patients with COVID-19 and acute kidney injury: A single-center experience in a time of crisis in the United States. Am J Kidney Dis 2020; 76:401−406. doi: 10.1053/j.ajkd.2020.06.00110.1053/j.ajkd.2020.06.001)| false
• Search Google Scholar
• Export Citation

Perkovic V, et al.. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 2019; 380:2295−2306. doi: 10.1056/nejmoa1811744

• Crossref
Perkovic V, . Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 2019; 380:2295−2306. doi: 10.1056/nejmoa181174410.1056/NEJMoa1811744)| false
• Search Google Scholar
• Export Citation

Heerspink HJL, et al.. Dapagliflozin in patients with chronic kidney disease. N Engl J Med 2020; 383:1436−1446. doi: 10.1056/NEJMoa2024816

• Crossref
Heerspink HJL, . Dapagliflozin in patients with chronic kidney disease. N Engl J Med 2020; 383:1436−1446. doi: 10.1056/NEJMoa202481610.1056/NEJMoa2024816)| false
• Search Google Scholar
• Export Citation

Agarwal R, et al.. Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine. Eur Heart J [published online ahead of print October 25, 2020]. doi: 10.1093/eurheartj/ehaa736; https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa736/5936792

Agarwal R, . Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine. Eur Heart J [published online ahead of print October 25, 2020]. doi: 10.1093/eurheartj/ehaa736; https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa736/5936792)| false
• Search Google Scholar
• Export Citation

Brown NJ. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol 2013; 9:459–469. doi: 10.1038/nrneph.2013.110

• Crossref
Brown NJ. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol 2013; 9:459–469. doi: 10.1038/nrneph.2013.11010.1038/nrneph.2013.110)| false
• Search Google Scholar
• Export Citation

Walsh M, et al.. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med 2020; 382:622−631. doi: 10.1056/nejmoa1803537

• Crossref
Walsh M, . Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med 2020; 382:622−631. doi: 10.1056/nejmoa180353710.1056/NEJMoa1803537)| false
• Search Google Scholar
• Export Citation

Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945; 102:400−401. doi: 10.1126/science.102.2651.400

• Crossref
Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945; 102:400−401. doi: 10.1126/science.102.2651.40010.1126/science.102.2651.400)| false
• Search Google Scholar
• Export Citation

Morath C, et al.. Phase I trial of donor-derived modified immune cell infusion in kidney transplantation. J Clin Invest 2020; 130:2364−2376. doi: 10.1172/jci133595

• Crossref
Morath C, . Phase I trial of donor-derived modified immune cell infusion in kidney transplantation. J Clin Invest 2020; 130:2364−2376. doi: 10.1172/jci13359510.1172/JCI133595)| false
• Search Google Scholar
• Export Citation

Levey AS, et al.. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461–470. doi: 10.7326/0003-4819-130-6-199903160-00002

• Crossref
Levey AS, . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461–470. doi: 10.7326/0003-4819-130-6-199903160-0000210.7326/0003-4819-130-6-199903160-00002)| false
• Search Google Scholar
• Export Citation

Levey AS, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604–612. doi: 10.7326/0003-4819-150-9-200905050-00006

• Crossref
Levey AS, . A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604–612. doi: 10.7326/0003-4819-150-9-200905050-0000610.7326/0003-4819-150-9-200905050-00006)| false
• Search Google Scholar
• Export Citation

National Kidney Foundation. NKF and ASN Form Joint Task Force to Focus on Use of Race in eGFR. 2020. https://www.kidney.org/newsletter/nkf-and-asn-form-joint-task-force-to-focus-use-race-egfr#:∼:text=NKF%20and%20ASN%20form%20joint%20task%20force%20to,on%20the%20use%20of%20race%20to%20estimate%20GFR

National Kidney Foundation. NKF and ASN Form Joint Task Force to Focus on Use of Race in eGFR. 2020. https://www.kidney.org/newsletter/nkf-and-asn-form-joint-task-force-to-focus-use-race-egfr#:∼:text=NKF%20and%20ASN%20form%20joint%20task%20force%20to,on%20the%20use%20of%20race%20to%20estimate%20GFR)| false
• Search Google Scholar
• Export Citation

US National Library of Medicine. EMPA-KIDNEY (The Study of Heart and Kidney Protection with Empagliflozin). ClinicalTrials.gov: NCT03594110. https://clinicaltrials.gov/ct2/show/NCT03594110

US National Library of Medicine. EMPA-KIDNEY (The Study of Heart and Kidney Protection with Empagliflozin). ClinicalTrials.gov: NCT03594110. https://clinicaltrials.gov/ct2/show/NCT03594110)| false
• Search Google Scholar
• Export Citation

Bakris GL, et al.. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 2020; 383:2219−2229. doi: 10.1056/NEJMoa2025845

• Crossref
Bakris GL, . Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 2020; 383:2219−2229. doi: 10.1056/NEJMoa202584510.1056/NEJMoa2025845)| false
• Search Google Scholar
• Export Citation

US National Library of Medicine. Efficacy and Safety of Finerenone in Subjects with Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD). ClinicalTrials.gov: NCT02545049. https://clinicaltrials.gov/ct2/show/NCT02545049

US National Library of Medicine. Efficacy and Safety of Finerenone in Subjects with Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD). ClinicalTrials.gov: NCT02545049. https://clinicaltrials.gov/ct2/show/NCT02545049)| false
• Search Google Scholar
• Export Citation

Saran R, et al.. US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2020; 75 (1 Suppl 1):A6−A7. doi: 10.1053/j.ajkd.2019.09.003

• Crossref
Saran R, . US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2020; 75 (1 Suppl 1):A6−A7. doi: 10.1053/j.ajkd.2019.09.00310.1053/j.ajkd.2019.09.003)| false
• Search Google Scholar
• Export Citation

Schiller B, et al.. Perceptions about renal replacement therapy among nephrology professionals. Nephrol News Issues 2010; 24:36, 38, 40 passim. PMID: 20942330

Schiller B, . Perceptions about renal replacement therapy among nephrology professionals. Nephrol News Issues 2010; 24:36, 38, 40 passim. PMID: 20942330)| false
• Search Google Scholar
• Export Citation

Trump DJ. Executive Order on Advancing American Kidney Health. July 10, 2019. https://www.whitehouse.gov/presidential-actions/executive-order-advancing-american-kidney-health/

Trump DJ. Executive Order on Advancing American Kidney Health. July 10, 2019. https://www.whitehouse.gov/presidential-actions/executive-order-advancing-american-kidney-health/)| false
• Search Google Scholar
• Export Citation

Centers for Medicare & Medicaid Services. Trump Administration Finalizes Transformative Medicare Payment Changes to Support Innovation in Kidney Care and Incentivize Dialysis in the Home. November 2, 2020. https://www.cms.gov/newsroom/press-releases/trump-administration-finalizes-transformative-medicare-payment-changes-support-innovation-kidney

Centers for Medicare & Medicaid Services. Trump Administration Finalizes Transformative Medicare Payment Changes to Support Innovation in Kidney Care and Incentivize Dialysis in the Home. November 2, 2020. https://www.cms.gov/newsroom/press-releases/trump-administration-finalizes-transformative-medicare-payment-changes-support-innovation-kidney)| false
• Search Google Scholar
• Export Citation

Sparks MA, et al.. Severe acute respiratory syndrome coronavirus 2, COVID-19, and the renin-angiotensin system: Pressing needs and best research practices. Hypertension 2020; 76:1350−1367. doi: 10.1161/HYPERTENSIONAHA.120.15948

• Crossref
Sparks MA, . Severe acute respiratory syndrome coronavirus 2, COVID-19, and the renin-angiotensin system: Pressing needs and best research practices. Hypertension 2020; 76:1350−1367. doi: 10.1161/HYPERTENSIONAHA.120.1594810.1161/HYPERTENSIONAHA.120.15948)| false
• Search Google Scholar
• Export Citation

Ng JH, et al.. Outcomes among patients hospitalized with COVID-19 and acute kidney injury. Am J Kidney Dis [published online ahead of print September 19, 2020]. doi: 10.1053/j.ajkd.2020.09.002; https://www.ajkd.org/article/S0272-6386(20)30998-7/fulltext

Ng JH, . Outcomes among patients hospitalized with COVID-19 and acute kidney injury. Am J Kidney Dis [published online ahead of print September 19, 2020]. doi: 10.1053/j.ajkd.2020.09.002; https://www.ajkd.org/article/S0272-6386(20)30998-7/fulltext)| false
• Search Google Scholar
• Export Citation

Ng JH, et al.. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int 2020; 98:1530−1539. doi: 10.1016/j.kint.2020.07.030

• Crossref
Ng JH, . Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int 2020; 98:1530−1539. doi: 10.1016/j.kint.2020.07.03010.1016/j.kint.2020.07.030)| false
• Search Google Scholar
• Export Citation